Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
12/09/2025
Rosenblatt has lowered the target price for New Think Technology from $650 to $605 and downgraded the rating from "buy" to "neutral."
Latest
1 m ago
Trade in Services Fair focuses on future industries and technology services.
3 m ago
Banco Sabadell of Spain: The board of directors unanimously believes that it is appropriate to advise its shareholders not to participate in the exchange offer proposed by Banco Bilbao Vizcaya Argentaria (BBVA) of Spain. They believe that the offer does not fully reflect the intrinsic value of Banco Sabadell's stock.
3 m ago
Banco Sabadell of Spain: Regarding the acquisition offer from a foreign bank, the board unanimously believes that it is appropriate to advise its shareholders not to participate in the stock exchange offer proposed by the foreign bank. The board considered that the offer does not adequately reflect the intrinsic value of Banco Sabadell's stock.
4 m ago
The Taiwan Stock Exchange Weighted Index closed 1% higher at 25,474.64.
7 m ago
DeepMind CEO: Artificial intelligence has the potential to shorten the drug development cycle to just a few months.
See all latest